Dr. Shervin Gholizadeh

Research Scientist
Tehran University of Medical Sciences, Iran

Highest Degree
Pharm.D in Pharmacy from Tehran University of Medical Sciences, Tehran, Iran

My URL
https://livedna.org/98.6597

Share this Profile

Biography

Dr. Shervin Gholizadeh obtained his Pharm.D in Pharmacy from Tehran University of Medical Sciences, Tehran, Iran. His main area of interest related to Pharmacology and Toxicology, Molecular Sciences, and Neuroscience. His area of expertise includes Behavioral Pharmacology, Seizure, Fragile X Syndrome, Autism, Gene therapy, Viral Vectors, and Associative Memory. He has published 13 research articles in journals, 1 book, and 11 abstracts contributed as author/co-author.

Area of Interest:

Pharmacology and Toxicology
Neuroscience
Behavioural Pharmacology
Epilepsy
Clinical Pharmacy

Selected Publications

  1. Gholizadeh, S., S. Tharmalingam, M.E. MacAldaz and D.R. Hampson, 2013. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Human Gene Ther. Methods, 24: 205-213.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Hampson, D.R., S. Gholizadeh and L.K.K. Pacey, 2012. Pathways to drug development for autism spectrum disorders. Clin. Pharmacol. Ther., 91: 189-200.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Lintas, A., N. Chi, N.M. Lauzon, S.F. Bishop and S. Gholizadeh et al., 2011. Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. J. Neurosci., 31: 11172-11183.
    CrossRef  |  Direct Link  |  

  4. Hosseini-Zare, M.S., F. Salehi, S.Y. Seyedi, K. Azami and T. Ghadiri et al., 2011. Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice. Eur. J. Pharmacol., 670: 464-470.
    CrossRef  |  PubMed  |  Direct Link  |  

  5. Bishop, S.F., N.M. Lauzon, M. Bechard, S. Gholizadeh and S.R. Laviolette, 2011. NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates. Cereb. Cortex, 21: 68-80.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Karimfar, M.H., S. Gholizadeh, A.P. Hajrasouliha, A.H. Miri and K. Tabrizian et al., 2009. Low dose morphine enhances morphine antinociception effects in the animals pretreated with selective and non-selective phosphodiestrase inhibitors. Iran. J. Pharm. Sci., 5: 73-81.
    Direct Link  |  

  7. Esmaeili, B., Z. Basseda, S. Gholizadeh, M.J. Paydar and A.R. Dehpour, 2009. Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol. Psychopharmacol., 204: 191-201.
    CrossRef  |  PubMed  |  Direct Link  |  

  8. Sharifzadeh, M., F. Shamsa, S. Shiran, M.H. Karimfar and A.H. Miri et al., 2008. A time course analysis of systemic administration of aqueous licorice extract on spatial memory retention in rats. Planta Med., 74: 485-490.
    CrossRef  |  PubMed  |  Direct Link  |  

  9. Bahremand, A., H. Shafaroodi, M. Ghasemi, S.E. Nasrabady and S. Gholizadeh et al., 2008. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice. Epilepsy Res., 81: 44-51.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Sharifzadeh, M., M. Aghsami, S. Gholizadeh, K. Tabrizian and M. Soodi et al., 2007. Protective effects of chronic lithium treatment against spatial memory retention deficits induced by the protein kinase AII inhibitor H-89 in rats. Pharmacol., 80: 158-165.
    CrossRef  |  PubMed  |  Direct Link  |  

  11. Sharifzadeh, M., A.R. Zamanian, S. Gholizadeh, K. Tabrizian and M. Etminani et al., 2007. Post-training intrahippocampal infusion of nicotine-bucladesine combination causes a synergistic enhancement effect on spatial memory retention in rats. Eur. J. Pharmacol., 562: 212-220.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Gholizadeh, S., H. Shafaroodi, M. Ghasemi, A. Bahremand and M. Sharifzadeh et al., 2007. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Neuropharmacol., 53: 763-770.
    CrossRef  |  PubMed  |  Direct Link  |  
Member since October, 2015